Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 11 - Drugs for disorders of the respiratory system
Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
04/2012
04/25/2012CN101967204B 太子参多糖在润肺镇咳中的应用 Taizishen polysaccharide used in the lungs and cough in
04/25/2012CN101961335B 一种含恩诺沙星六水合物组合物及其在制备治疗或预防家禽疾病的药物中的应用 And its application in the manufacture of a medicament for treating or preventing disease in poultry in the composition containing enrofloxacin hexahydrate
04/25/2012CN101947274B 具有抗菌消炎作用的中药组合物的检测方法 Detection of anti-inflammatory medicine with antimicrobial compositions
04/25/2012CN101891747B Compound capable of inhibiting phosphodiesterase type 5 and preparation method
04/25/2012CN101862357B 山香圆叶总黄酮乙醇回流提取物及其制备方法和用途 Yamaga round leaves flavonoids ethanol extraction and preparation method and uses
04/25/2012CN101849953B 炎症性细胞因子产生游离抑制剂 Inflammatory cytokine production inhibitor free
04/25/2012CN101843845B 一种治疗慢性咽炎的中药祛炎合剂及制备方法 Chinese medicine for treating chronic pharyngitis remove inflammatory agent and preparation method
04/25/2012CN101791338B 抗流感药物、其制备方法及应用 Anti-influenza drug, and its preparation method and application
04/25/2012CN101747432B 一种α1-抗胰蛋白酶药物的制备方法 One kind of α1- antitrypsin preparation of drugs
04/25/2012CN101574395B 一种采用高电压脉冲电场技术生产五味子提取物的方法 A method using high voltage pulsed electric field technology to produce extracts of Schisandra
04/25/2012CN101511831B 作为a2a受体激动剂的腺苷衍生物 As the derivatives of adenosine a2a agonist
04/25/2012CN101337000B 龙葵提取物、其制备方法及其药物用途 Solanum nigrum extract, their preparation and their pharmaceutical use
04/25/2012CN101069744B 流感疫苗组合物 Influenza vaccine composition
04/25/2012CN101006077B Crystalline form of a biphenyl compound
04/24/2012US8163803 Compounds derived from lidocaine, pharmaceutical compositions, use and method of treatment, prevention or inhibition of disease
04/24/2012US8163754 Purine derivatives for use as adenosine A-2A receptor agonists
04/24/2012US8163751 Acylated indanyl amines and their use as pharmaceuticals
04/24/2012US8163743 4-carboxamide indazole derivatives useful as inhibitors of PI3-kinases
04/24/2012US8163733 Sulfonylamino-derivatives as novel inhibitors of histone deacetylase
04/24/2012US8163723 Combination of azelastine and steroids
04/24/2012US8163719 Regulators of the hedgehog pathway, compositions and uses related thereto
04/24/2012US8163299 Stabilized pharmaceutical product
04/24/2012CA2472582C Sterile filtered nanoparticulate formulations of budesonide and beclomethasone having tyloxapol as a surface stabilizer
04/24/2012CA2466036C Taste masking spill-resistant formulation
04/24/2012CA2452447C Antagonistic anti-htnfsf13b human antibodies
04/24/2012CA2433807C Hydrophobic polyamine analogs and methods for their use
04/24/2012CA2433582C Peptides having inhibiting activity on the production of nitric oxide
04/24/2012CA2425599C Fumaric acid amides
04/19/2012WO2012051339A2 Methods and compositions for treating respiratory conditions using platelet enriched plasma
04/19/2012WO2012051111A2 Human oncostatin m antibodies and methods of use
04/19/2012WO2012051103A1 Serotonin reuptake inhibitors
04/19/2012WO2012050945A1 Cationic dry powders
04/19/2012WO2012050181A1 Prophylactic or therapeutic agent for fibrosis
04/19/2012WO2012048526A1 Chinese medicine product for clearing lungs, relieving asthma, and reducing phlegm
04/19/2012WO2012022796A3 Novel combinations
04/19/2012WO2012016889A3 Dry powder formulation comprising a phosphodiesterase inhibitor
04/19/2012WO2011149881A3 Methods for the treatment and prevention of inflammatory diseases
04/19/2012WO2011140305A3 Method of producing pleurodesis
04/19/2012WO2011116161A3 Arylsulfonamide ccr3 antagonists
04/19/2012US20120096569 Anti-il-6 antibodies,compositions, methods and uses
04/19/2012US20120095090 Novel composition and method for stabilizing the same
04/19/2012US20120095071 3-(3-indolyl) propionic acid calcium salt and method of making 3-(3-indolyl) propionic acid free acid therefrom
04/19/2012US20120095062 Tricyclic compounds, compositions, and methods
04/19/2012US20120095060 Methods and compositions of mitogen-activated protein kinase (mapk) pathway inhibitors for treating pulmonary fibrosis
04/19/2012US20120095056 2,5-disubstituted tetrazole derivatives and their use as nicotinic acetylcholine receptor modulators
04/19/2012US20120095055 HEXAHYDROCYCLOPENTYL[f]INDAZOLE 5-HYDROXYMETHYL ETHANOLS AND DERIVATIVES THEREOF AS SELECTIVE GLUCOCORTICOID RECEPTOR MODULATORS
04/19/2012US20120095053 Aminotetrahydroindazoloacetic acids
04/19/2012US20120095049 Nociceptin analogs
04/19/2012US20120095046 Amido-Isothiazole Compounds and Their Use as Inhibitors of 11Beta-HSD1 for the Treatment of Metabolic Syndrome and Related Disorders
04/19/2012US20120095040 Cyclopenta[c]pyrrole-2-carboxylate derivatives, preparation thereof and therapeutic use thereof
04/19/2012US20120095033 Selective Glycosidase Inhibitors and Uses Thereof
04/19/2012US20120095025 SUBSTITUTED [1,2,4]TRIAZOLO[1,5-a]PYRIMIDINES AND THEIR USE AS POTASSIUM CHANNEL MODULATORS
04/19/2012US20120095024 Toluidine sulfonamides and their use
04/19/2012US20120095022 Derivatives of 10-amino-1,2,3,4-tetrahydropyrido[2,1-a]isoindol-6(10bh)-ones, method for preparation thereof and therapeutic uses thereof
04/19/2012US20120095012 Toluidine sulfonamides and their use
04/19/2012US20120095010 Tricyclic delta-opioid modulators
04/19/2012US20120095006 Treatment of pulmonary hypertension
04/19/2012US20120095005 Fused Bicyclic Pyrazole Derivatives As Kinase Inhibitors
04/19/2012US20120095004 Sphingosine Kinase Inhibitors
04/19/2012US20120095003 Methods of using prodrugs of methyl hydrogen fumarate and pharmaceutical compositions thereof
04/19/2012US20120095002 Isoxazole-5-carboxamide derivatives
04/19/2012US20120094990 Phenylacetic acid compound
04/19/2012US20120094987 SUBSTITUTED PYRIDO [3', 2': 4, 5] THIENO [3, 2-D] PYRIMIDINES AND PYRIDO [3', 2': 4, 5] FURO [3, 2-D] PYRIMIDINES USED AS INHIBITORS OF THE PDE-4 AND/OR THE RELEASE OF TNF-alpha
04/19/2012US20120094979 Thiazole or thiadizaloe derivatives for use as sphingosine 1-phosphate 1 (s1p1) receptor agonists
04/19/2012US20120094970 NON-HORMONAL STEROID MODULATORS OF NF-kB FOR TREATMENT OF DISEASE
04/19/2012US20120094968 Sulfonic amide and sulfoximine-substttuted diaryl-dihydropyrimidinones and usage thereof
04/19/2012US20120094967 Compositions and methods for treating asthma and other lung diseases
04/19/2012US20120094966 Organic compounds
04/19/2012US20120094964 Sulfamoyl benzoic acid derivatives as trpm8 antagonists
04/19/2012US20120094945 Discovery of Selective Glucocorticoid Receptor Modulators by Multiplexed Reporter Screening
04/19/2012US20120094944 Novel imidazopyridine compound
04/19/2012US20120094941 Mangiferin-Berberine Salt, Manufacturing Method and Use Thereof
04/19/2012US20120094938 Small Peptides And Methods For Treatment Of Chronic Inflammatory Bowel Disease
04/19/2012US20120094918 Method of using diketopiperazines and composition containing them
04/19/2012US20120094904 Fad4, fad5, fad5-2, and fad6, novel fatty acid desaturase family members and uses thereof
04/19/2012US20120094893 Method of using diketopiperazines and composition containing them
04/19/2012US20120093948 Nitric Oxide Treatments
04/19/2012US20120093947 Method of treating reactive airway disease
04/19/2012US20120093901 Method for producing free powder particles of polyamide impregnated with at least one cosmetic or pharmaceutical agent, and free powder particles of polyamide having a content of at least 25 wt % of a cosmetic or pharmaceutical agent other than water
04/19/2012US20120093893 Highly Efficient Delivery of a Large Therapeutic Mass Aerosol
04/19/2012US20120093890 Inhalable aztreonam for treatment and prevention of pulmonary bacterial infections
04/19/2012US20120093883 Method of treating and preventing neuro-olfactory triggered or aggravated illnesses or related conditions
04/19/2012US20120093875 Aminocyclitol compounds, process for obtaining them and uses
04/19/2012US20120093833 Human Oncostatin M Antibodies and Methods of Use
04/19/2012US20120093829 New methods for treatment of inflammatory diseases
04/19/2012US20120093810 Monoclonal antibody capable of binding to specific discontinuous epitope occurring in ad1 region of human cytomegalovirus gb glycoprotein, and antigen-binding fragment thereof
04/19/2012US20120093796 Novel use of ec-sod and method for preparing thereof
04/19/2012US20120093791 Stimulation of innate immunity with an antigen from bacterial origin
04/19/2012US20120091605 Chewable Soft Capsule
04/19/2012CA2814194A1 Antitussive compositions comprising memantine
04/19/2012CA2813750A1 Method for treating cystic fibrosis with inhaled denufosol
04/19/2012CA2813163A1 Prophylactic or therapeutic agent for fibrosis
04/19/2012CA2812417A1 Cationic dry powders
04/19/2012CA2811641A1 Serotonin reuptake inhibitors
04/18/2012EP2441455A1 Methods of administering pirfenidone therapy
04/18/2012EP2440238A1 Methods of treatment
04/18/2012EP2440196A1 Treatment of chronic obstructive pulmonary disease with nebulized beta 2-agonist or combined nebulized beta 2-agonist and anticholinergic administration
04/18/2012EP2197477B1 Use of lvv-hemorphin-6 and optionally af12198 as therapeutic agent(s)
04/18/2012EP2176238B1 Morpholino pyrimidine derivatives used in diseases linked to mtor kinase and/or pi3k
04/18/2012EP2131829B1 PPAR-gamma agonists for the induction of cationic antimicrobial peptide expression as immunoprotective stimulants
1 ... 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 ... 878